Stocks and Investing Stocks and Investing
Mon, May 8, 2023

Salim Syed Maintained (BBIO) at Strong Buy with Increased Target to $29 on, May 8th, 2023


Published on 2024-10-28 03:29:59 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $23 to $29 on, May 8th, 2023.

Salim has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Salim's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Salim


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Wednesday, April 19th, 2023
  • Mani Foroohar of "SVB Securities" Maintained at Buy with Increased Target to $27 on, Thursday, April 13th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, March 7th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Tuesday, March 7th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $29 on, Tuesday, March 7th, 2023
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023
Contributing Sources